-
Signature
-
/s/ Joan Aristei, as Attorney-in-Fact for Dan Preston
-
Issuer symbol
-
DAVE
-
Transactions as of
-
12 Nov 2024
-
Net transactions value
-
-$911,908
-
Form type
-
4
-
Filing time
-
14 Nov 2024, 17:38:46 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
DAVE |
Class A Common Stock |
Options Exercise |
$2,228 |
+2,360 |
+10% |
$0.9440 |
25,355 |
12 Nov 2024 |
Direct |
|
| transaction |
DAVE |
Class A Common Stock |
Sale |
$151,040 |
-2,360 |
-9.3% |
$64.00 |
22,995 |
12 Nov 2024 |
Direct |
F1 |
| transaction |
DAVE |
Class A Common Stock |
Options Exercise |
$9,218 |
+9,765 |
+42% |
$0.9440 |
32,760 |
13 Nov 2024 |
Direct |
|
| transaction |
DAVE |
Class A Common Stock |
Sale |
$772,314 |
-9,765 |
-30% |
$79.09 |
22,995 |
13 Nov 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
DAVE |
Stock Option (right to buy) |
Options Exercise |
$0 |
-2,360 |
-19% |
$0.000000 |
9,765 |
12 Nov 2024 |
Class A Common Stock |
2,360 |
$0.9440 |
Direct |
F2 |
| transaction |
DAVE |
Stock Option (right to buy) |
Options Exercise |
$0 |
-9,765 |
-100% |
$0.000000 |
0 |
13 Nov 2024 |
Class A Common Stock |
9,765 |
$0.9440 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: